TY - JOUR AU - Holderfield, M. AU - Deuker, M. M. AU - McCormick, F. AU - McMahon, M. AU - Targeting, R. A. F. PY - 2014 DA - 2014// TI - Kinases for cancer therapy: BRAF-mutated melanoma and beyond JO - Nat Rev Cancer VL - 14 UR - https://doi.org/10.1038/nrc3760 DO - 10.1038/nrc3760 ID - Holderfield2014 ER - TY - JOUR AU - Hu-Lieskovan, S. AU - Robert, L. AU - Homet Moreno, B. AU - Ribas, A. PY - 2014 DA - 2014// TI - Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.52.1377 DO - 10.1200/JCO.2013.52.1377 ID - Hu-Lieskovan2014 ER - TY - JOUR AU - Sharma, P. AU - Allison, J. P. PY - 2015 DA - 2015// TI - Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential JO - Cell VL - 161 UR - https://doi.org/10.1016/j.cell.2015.03.030 DO - 10.1016/j.cell.2015.03.030 ID - Sharma2015 ER - TY - JOUR AU - Mahoney, K. M. AU - Rennert, P. D. AU - Freeman, G. J. PY - 2015 DA - 2015// TI - Combination cancer immunotherapy and new immunomodulatory targets JO - Nat Rev Drug Discov VL - 14 UR - https://doi.org/10.1038/nrd4591 DO - 10.1038/nrd4591 ID - Mahoney2015 ER - TY - JOUR AU - Restifo, N. P. AU - Smyth, M. J. AU - Snyder, A. PY - 2016 DA - 2016// TI - Acquired resistance to immunotherapy and future challenges JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2016.2 DO - 10.1038/nrc.2016.2 ID - Restifo2016 ER - TY - JOUR AU - Sullivan, R. J. AU - Flaherty, K. T. PY - 2013 DA - 2013// TI - Resistance to BRAF-targeted therapy in melanoma JO - Eur J Cancer VL - 49 UR - https://doi.org/10.1016/j.ejca.2012.11.019 DO - 10.1016/j.ejca.2012.11.019 ID - Sullivan2013 ER - TY - JOUR AU - Kelderman, S. AU - Schumacher, T. N. AU - Haanen, J. B. PY - 2014 DA - 2014// TI - Acquired and intrinsic resistance in cancer immunotherapy JO - Mol Oncol VL - 8 UR - https://doi.org/10.1016/j.molonc.2014.07.011 DO - 10.1016/j.molonc.2014.07.011 ID - Kelderman2014 ER - TY - JOUR AU - Larkin, J. AU - Hodi, F. S. AU - Wolchok, J. D. PY - 2015 DA - 2015// TI - Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504030 DO - 10.1056/NEJMoa1504030 ID - Larkin2015 ER - TY - JOUR AU - Hodi, F. S. AU - Chesney, J. AU - Pavlick, A. C. AU - Robert, C. AU - Grossmann, K. F. AU - McDermott, D. F. AU - Linette, G. P. PY - 2016 DA - 2016// TI - Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30366-7 DO - 10.1016/S1470-2045(16)30366-7 ID - Hodi2016 ER - TY - JOUR AU - Hernandez, J. AU - Thompson, I. M. PY - 2004 DA - 2004// TI - Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker JO - Cancer VL - 101 UR - https://doi.org/10.1002/cncr.20480 DO - 10.1002/cncr.20480 ID - Hernandez2004 ER - TY - JOUR AU - Grunnet, M. AU - Sorensen, J. B. PY - 2012 DA - 2012// TI - Carcinoembryonic antigen (CEA) as tumor marker in lung cancer JO - Lung Cancer VL - 76 UR - https://doi.org/10.1016/j.lungcan.2011.11.012 DO - 10.1016/j.lungcan.2011.11.012 ID - Grunnet2012 ER - TY - JOUR AU - Alix-Panabieres, C. AU - Pantel, K. PY - 2016 DA - 2016// TI - Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy JO - Cancer Discov VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-15-1483 DO - 10.1158/2159-8290.CD-15-1483 ID - Alix-Panabieres2016 ER - TY - STD TI - Lee JH, Long GV, Boyd S, Lo S, Menzies AM, Tembe V, Guminski A, et al. Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma. Ann Oncol. 2017; ID - ref13 ER - TY - STD TI - Bast RC, Jr., Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, Baggerly KA, et al. New tumor markers: CA125 and beyond. Int J Gynecol Cancer 2005;15 Suppl 3:274–281. ID - ref14 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. AU - Schwartz, L. H. AU - Sargent, D. AU - Ford, R. AU - Dancey, J. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Gold, L. AU - Ayers, D. AU - Bertino, J. AU - Bock, C. AU - Bock, A. AU - Brody, E. N. AU - Carter, J. PY - 2010 DA - 2010// TI - Aptamer-based multiplexed proteomic technology for biomarker discovery JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0015004 DO - 10.1371/journal.pone.0015004 ID - Gold2010 ER - TY - JOUR AU - Khan, A. PY - 2012 DA - 2012// TI - Detection and quantitation of forty eight cytokines, chemokines, growth factors and nine acute phase proteins in healthy human plasma, saliva and urine JO - J Proteome VL - 75 UR - https://doi.org/10.1016/j.jprot.2012.05.018 DO - 10.1016/j.jprot.2012.05.018 ID - Khan2012 ER - TY - JOUR AU - Reich, M. AU - Liefeld, T. AU - Gould, J. AU - Lerner, J. AU - Tamayo, P. AU - Mesirov, J. P. PY - 2006 DA - 2006// TI - GenePattern 2.0 JO - Nat Genet VL - 38 UR - https://doi.org/10.1038/ng0506-500 DO - 10.1038/ng0506-500 ID - Reich2006 ER - TY - JOUR AU - Metsalu, T. AU - Vilo, J. PY - 2015 DA - 2015// TI - ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap JO - Nucleic Acids Res VL - 43 UR - https://doi.org/10.1093/nar/gkv468 DO - 10.1093/nar/gkv468 ID - Metsalu2015 ER - TY - STD TI - Discovery Assay - Eve Technologies. Eve Technologies Corporation; 2017. ID - ref20 ER - TY - JOUR AU - Breen, E. J. AU - Polaskova, V. AU - Khan, A. PY - 2015 DA - 2015// TI - Bead-based multiplex immuno-assays for cytokines, chemokines, growth factors and other analytes: median fluorescence intensities versus their derived absolute concentration values for statistical analysis JO - Cytokine VL - 71 UR - https://doi.org/10.1016/j.cyto.2014.10.030 DO - 10.1016/j.cyto.2014.10.030 ID - Breen2015 ER - TY - JOUR AU - Breen, E. J. AU - Tan, W. AU - Khan, A. PY - 2016 DA - 2016// TI - The statistical value of raw fluorescence signal in Luminex xMAP based multiplex immunoassays JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep26996 DO - 10.1038/srep26996 ID - Breen2016 ER - TY - STD TI - SOMAscan Assay: An unprecedented protein biomarker discovery and development tool. SOMALOGIC, INC.; 2017. ID - ref23 ER -